On August 23, 2021 Vaccibody AS, a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, reported that it will hold a webcast to discuss the results for the first half of 2021 on August 26, 2021 at 10 am CEST (Press release, Vaccibody, AUG 23, 2021, View Source/wp-content/uploads/2021/08/210823_PR_Vaccibody_Q2-2021-report-webcast_final-1.pdf" target="_blank" title="View Source/wp-content/uploads/2021/08/210823_PR_Vaccibody_Q2-2021-report-webcast_final-1.pdf" rel="nofollow">View Source [SID1234586809]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webcast will be in English and may be viewed here: View Source Further, the slide presentation will be available on Vaccibody’s website at View Source